Similar companies
Income Statement (USD)
| Q2 '25 | QoQ | |
|---|---|---|
| Revenue | 11M | 20.6% |
| Gross Profit | 7.1M | 25% |
| Cost of Revenue | 4.3M | 13.9% |
| Operating expense | 5.4M | 38.4% |
| Net Income | -3.8M | 9% |
| EBITDA | -2.6M | 15.6% |
Balance Sheet (USD)
| Q2 '25 | QoQ | |
|---|---|---|
| Total Assets | 58M | 3.3% |
| Total Liabilities | 51M | 2.5% |
| Total Equity | 7.3M | 31% |
| Shares Outstanding | 41M | 14.6% |
Cash Flow (USD)
| Q2 '25 | QoQ | |
|---|---|---|
| Cash from operations | -1.2M | 75.6% |
| Cash from investing | -270,000 | 381.8% |
| Cash from financing | 25,000 | 0% |
EPS
Financial Highlights for Apyx Medical in Q2 '25
Apyx Medical reported a revenue of 11M, which is a 20.6% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 7.1M, marking a 25% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 4.3M, a 13.9% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 5.4M, showing a -38.4% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -3.8M, showing a 9% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was -2.6M, showing a 15.6% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
It was a positive quarter for Apyx Medical with growth in revenue, gross profit, and net income.
